Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland, USA.
Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North, USA.
Cancer Med. 2022 Apr;11(8):1913-1922. doi: 10.1002/cam4.4563. Epub 2022 Feb 12.
Hispanic/Latina women are less likely to be diagnosed with local stage breast cancer than White women. Additionally, foreign-born women have lower mammography rates than US-born women. We evaluated the combined effect of birthplace and race/ethnicity on screening habits of women at higher-than-average risk of breast cancer.
Multinomial logistic regression was used to evaluate breast cancer screening in 44,524 women in the Sister Study cohort. Screening methods ascertained at enrollment (2003-2009) included mammography, ultrasound, and magnetic resonance imaging. Timing of screening was assessed as recently (≤2 years ago), formerly (>2 years ago), and never screened. Adjustments included sociodemographic, socioeconomic, and health variables.
Most women in the sample were US-born non-Hispanic/Latina White (92%), were ≥50 years old (73%), had one first-degree female relative with breast cancer (73%), and were screened in the past two years (97%). US-born Hispanic/Latina women had higher odds (odds ratio [OR] = 1.47, 95% confidence interval [CI] = 1.08-2.00) than US-born non-Hispanic/Latina White women of not having received a breast cancer screening in the past 2 years, relative to a recent screening. Similarly, foreign-born Hispanic/Latina women had higher odds (OR = 1.63, 95% CI = 1.10-2.41) than US-born non-Hispanic/Latina White women of never having received a breast cancer screening.
We observed that Hispanic/Latina women have higher odds of never and dated breast cancer screenings compared to US-born White women. Birthplace and race/ethnicity each contribute to disparities in who receives preventative health care in the United States. It is critical to include birthplace when evaluating health behaviors in minority groups.
与白人女性相比,西班牙裔/拉丁裔女性被诊断为局部乳腺癌的可能性较低。此外,外国出生的女性比美国出生的女性进行乳房 X 光检查的比例更低。我们评估了出生地和种族/民族对乳腺癌高危女性筛查习惯的综合影响。
使用多项逻辑回归分析评估了姐妹研究队列中 44524 名女性的乳腺癌筛查情况。入组时(2003-2009 年)确定的筛查方法包括乳房 X 光检查、超声和磁共振成像。筛查时间评估为最近(≤2 年前)、以前(>2 年前)和从未筛查。调整因素包括社会人口统计学、社会经济和健康变量。
样本中大多数女性为美国出生的非西班牙裔/拉丁裔白人(92%),年龄≥50 岁(73%),有一名一级女性亲属患有乳腺癌(73%),且在过去两年内接受过筛查(97%)。与最近接受过筛查的女性相比,美国出生的西班牙裔/拉丁裔女性未在过去 2 年内接受过乳腺癌筛查的可能性更高(比值比 [OR] = 1.47,95%置信区间 [CI] = 1.08-2.00)。同样,与美国出生的非西班牙裔/拉丁裔白人女性相比,外国出生的西班牙裔/拉丁裔女性从未接受过乳腺癌筛查的可能性更高(OR = 1.63,95% CI = 1.10-2.41)。
我们观察到,与美国出生的白人女性相比,西班牙裔/拉丁裔女性接受乳腺癌筛查的可能性更高,要么从未进行过筛查,要么筛查时间间隔较长。出生地和种族/民族都对美国接受预防性保健服务的人群存在差异。在评估少数族裔的健康行为时,纳入出生地至关重要。